Comparison of metabolic changes after neoadjuvant endocrine and chemotherapy in ER-positive, HER2-negative breast cancer

Survival of breast cancer patients has improved, and treatment-related changes regarding metabolic profile deterioration after neoadjuvant systemic treatment (NST) become important issues in cancer survivors. We sought to compare metabolic profile changes and the neutrophil-to-lymphocyte ratio (NLR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Ho Hyun, Ahn, Sei Hyun, Kim, Seon Ok, Kim, Jeong Eun, Kim, Ji sun, Ahn, Jin-Hee, Jung, Kyung Hae, Kim, Sung-Bae, Ko, Beom Seok, Lee, Jong Won, Son, Byung Ho, Shin, Hee Jung, Kim, Hak Hee, Gong, Gyung yub, Kim, Hee Jeong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131718/
https://www.ncbi.nlm.nih.gov/pubmed/34006898
http://dx.doi.org/10.1038/s41598-021-89651-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131718/
https://www.ncbi.nlm.nih.gov/pubmed/34006898
http://dx.doi.org/10.1038/s41598-021-89651-0

Ejemplares similares